Literature DB >> 15306749

Thromboembolism and toxic shock syndrome: a case presentation and literature update.

U M Musharrafieh1, G W Jamaleddine, A T Taher, W Y Almawi, Z A Tabbara.   

Abstract

A case of progressive shock and multisystem organ failure is reported for an 18 year old Lebanese woman, clinically diagnosed as toxic shock syndrome (TSS). The patient developed cough and dyspnea during hospitalization; chest CT angiography revealed thromboembolism of the pulmonary artery. CBC analysis showed leukocytosis with a white cell count (WCC) with a marked increase in PT and PTT coupled with reduced protein S, antithrombin III, and protein C levels. The patient improved gradually and was discharged from the hospital 7 days later on oral anticoagulation, and was followed up for six months with no disease recurrence or complications. To our knowledge, this is the first reported case in the literature of toxic shock syndrome associated with pulmonary thromboembolism.

Entities:  

Mesh:

Year:  2004        PMID: 15306749     DOI: 10.1023/B:THRO.0000037669.90852.ed

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  20 in total

Review 1.  Disseminated intravascular coagulation.

Authors:  M Levi; H Ten Cate
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

2.  Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome.

Authors:  B K Eriksson; J Andersson; S E Holm; M Norgren
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

Review 3.  Toxic shock syndrome: broadening the differential diagnosis.

Authors:  C M Herzer
Journal:  J Am Board Fam Pract       Date:  2001 Mar-Apr

4.  Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.

Authors:  R M Mesters; P M Mannucci; R Coppola; T Keller; H Ostermann; J Kienast
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

5.  Prospectively validated prediction of organ failure and hypotension in patients with septic shock: the Systemic Mediator Associated Response Test (SMART).

Authors:  G J Slotman
Journal:  Shock       Date:  2000-08       Impact factor: 3.454

6.  Septic pulmonary thrombosis in streptococcal toxic shock syndrome.

Authors:  S F Cramer; Z M Tomkiewicz
Journal:  Hum Pathol       Date:  1995-10       Impact factor: 3.466

7.  Toxic shock syndrome: a perspective through the looking glass.

Authors:  J K Todd
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

8.  Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases.

Authors:  S M Larkin; D N Williams; M T Osterholm; R W Tofte; Z Posalaky
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

9.  Toxic shock syndrome surveillance in the United States, 1980 to 1981.

Authors:  A L Reingold; N T Hargrett; K N Shands; B B Dan; G P Schmid; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

10.  Case report: fatal non-menstrual toxic shock in a Chinese woman.

Authors:  R E Ambrose; H Cheung
Journal:  Clin Radiol       Date:  1992-05       Impact factor: 2.350

View more
  1 in total

1.  Pirfenidone attenuates cardiac hypertrophy against isoproterenol by inhibiting activation of the janus tyrosine kinase-2/signal transducer and activator of transcription 3 (JAK-2/STAT3) signaling pathway.

Authors:  Zhenhuan Chen; Haiwen Zhou; Xiantao Huang; Shaoyun Wang; Xiaochao Ouyang; Yunxia Wang; Qianqiang Cao; Liu Yang; Yu Tao; Hengli Lai
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.